Look for:

Products

NOVARTIS AG


ISIN:
CH0012005267
WKN:
1200526
2019/06/28 19:57:50
Price
80.16 EUR
Difference -0.27% (-0.22)

General attributes

ISINCH0012005267
SymbolNOVN
ExchangeFrankfurt
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)182,704 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open80.34 EUR
High80.34 EUR
Low79.94 EUR
Close (prev. day)80.38 EUR
VWAP80.2248 EUR
Volume (pcs)1,589
Trading volume127,477.20
Number of trades13
Last size62

Futures and Options

Related Futures30
Related Options-

PDF Downloads

Company report: NOVARTIS AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2019/06/28 19:57:50
Price
80.16 EUR
Difference -0.27% (-0.22)

General attributes

ISINCH0012005267
SymbolNOVN
ExchangeFrankfurt
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)182,704 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open80.34 EUR
High80.34 EUR
Low79.94 EUR
Close (prev. day)80.38 EUR
VWAP80.2248 EUR
Volume (pcs)1,589
Trading volume127,477.20
Number of trades13
Last size62

Performance and Risk

6m1Y3Y
Perf (%)+22.41%+44.35%+26.43%
Perf (abs.)+14.67+24.63+16.76
Beta0.470.500.64
Volatility17.3917.4817.04
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)80.76 EUR (1,970)
Ø price 30 days | Ø volume 30 days (pcs.)78.50 EUR (3,108)
Ø price 100 days | Ø volume 100 days (pcs.)73.79 EUR (4,364)
Ø price 250 days | Ø volume 250 days (pcs.)68.71 EUR (3,787)
YTD High | date82.30 EUR (2019/06/20)
YTD Low | date64.89 EUR (2019/01/03)
52 Weeks High | date82.30 EUR (2019/06/20)
52 Weeks Low | date56.38 EUR (2018/07/02)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2019/06/2822:2580.05 EUR1.31125
Stuttgart2019/06/2821:5880.10 EUR0.0411
SIX Swiss Exchange2022/08/1217:3080.10 CHF368.3414,511
London Stock Exchange European Trade Reporting2022/08/1217:2079.89 CHF26.5016
Hanover2019/06/2808:0180.10 EUR0.002
Hamburg2019/06/2814:0580.19 EUR0.084
Frankfurt2019/06/2819:5780.16 EUR0.1313
FINRA other OTC Issues2022/08/1216:1685.01 USD4.587
Duesseldorf2019/06/2814:0880.18 EUR0.002
Berlin2019/06/2818:4580.40 EUR0.0016

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2284&ID_TYPE_IMAGE_LOGO=2

Contact Details

NOVARTIS AG
- -
Lichtstrasse 35 - 4056 Basel
Telefon: 41-61-324-11-11
Fax: 41-61-324-80-01
E-mail: -

PDF Downloads

Company report: NOVARTIS AGPDF Download

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Members of Management Board

Vasant Narasimhan, M.D.Chairman of Managing Board
James E. BradnerMember of Executive Committee
Klaus MoosmayerMember of Executive Committee
Steffen LangMember of Executive Committee
Susanne SchaffertMember of Executive Committee
Harry KirschMember of Executive Committee
John Tsai, M.D.Member of Executive Committee
Karen L. HaleMember of Executive Committee
Marie-France TschudinMember of Executive Committee
Richard SaynorMember of Executive Committee
Rob KowalskiMember of Executive Committee
Robert WeltevredenMember of Executive Committee

Board of directors

Andreas von PlantaMember of the administrative board
Charles SawyersMember of the administrative board
Nancy AndrewsMember of the administrative board
Simon MoroneyMember of the administrative board
Ana de Pro GonzaloMember of the administrative board
Bridgette HellerMember of the administrative board
Daniel HochstrasserMember of the administrative board
Frans van HoutenMember of the administrative board
Mary DohertyMember of the administrative board
Patrice BulaMember of the administrative board
Ton BüchnerMember of the administrative board
William WintersMember of the administrative board
Hans Jörg ReinhardtChairman of the administrative boar





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.